Disease-centric intelligence
Navigate disease signatures with verified repositioning evidence.
Each disease workspace links to candidate drugs with graded evidence from PubMed, clinical trials, and regulatory sources.
Type 2 Diabetes MellitusICD-10 E11
No evidenceChronic metabolic disorder characterized by insulin resistance and progressive β-cell dysfunction.
Evidence pipeline pending
Open disease workspaceLaunch →Malignant neoplasm of breast tissue with heterogeneous molecular subtypes.
1 evidence record
Open disease workspaceLaunch →Pulmonary Arterial HypertensionICD-10 I27.0
Approved
Progressive narrowing of pulmonary arterioles leading to right heart failure.
1 evidence record
Open disease workspaceLaunch →Multiple MyelomaICD-10 C90.0
Approved
Plasma cell malignancy characterized by bone lesions, anemia, and renal impairment.
1 evidence record
Open disease workspaceLaunch →Strong Repurposing Signal
Acute respiratory disease caused by SARS-CoV-2 with variable severity and systemic inflammation.
2 evidence records
Open disease workspaceLaunch →Tuberous Sclerosis ComplexICD-10 Q85.1
Approved
Autosomal dominant disorder with hamartomas in multiple organs due to mTOR pathway dysregulation.
1 evidence record
Open disease workspaceLaunch →HypothyroidismICD-10 E03.9
Approved
Deficiency of thyroid hormone causing metabolic slowing, fatigue, and systemic symptoms.
1 evidence record
Open disease workspaceLaunch →Cardiovascular DiseaseICD-10 I25.9
Approved
Spectrum of atherosclerotic and thrombotic conditions affecting heart and vasculature.
1 evidence record
Open disease workspaceLaunch →Benign Prostatic HyperplasiaICD-10 N40
Approved
Non-malignant prostate enlargement causing lower urinary tract symptoms.
1 evidence record
Open disease workspaceLaunch →Androgenetic AlopeciaICD-10 L64
Approved
Pattern hair loss driven by androgen sensitivity and follicular miniaturization.
1 evidence record
Open disease workspaceLaunch →Rheumatoid ArthritisICD-10 M06.9
No evidenceAutoimmune inflammatory arthritis with symmetric joint involvement and systemic features.
Evidence pipeline pending
Open disease workspaceLaunch →Polycystic Ovary SyndromeICD-10 E28.2
No evidenceEndocrine disorder with hyperandrogenism, ovulatory dysfunction, and metabolic features.
Evidence pipeline pending
Open disease workspaceLaunch →Persistently elevated arterial blood pressure.
Evidence pipeline pending
Open disease workspaceLaunch →Erectile DysfunctionICD-10 N52.9
No evidenceInability to achieve or maintain erection sufficient for intercourse.
Evidence pipeline pending
Open disease workspaceLaunch →